Factors such as increasing public and private funding for life science research, the significantly high prevalence of target diseases across the globe, and increasing R&D spending by pharmaceutical and biotechnology companies are driving the growth of this market.

Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=36975865


Transfer membrane is a microporous membrane that is used in the detection, analysis of the proteins and nucleic acids. These are also used to transferring proteins from gel matrices. These transfer membranes are used in various blotting techniques such as northern, southern, western and protein sequencing.

Market Segmentation

On the basis of types, the transfer membrane market is classified into nylon transfer membrane, nitrocellulose transfer membrane, and PVDF transfer membranes. In 2018, PVDF transfer membranes are expected to command the major share of the transfer membrane market.. The PVDF transfer membrane segment is expected to account for the largest share of the transfer membrane market

On the basis of transfer method, the transfer membrane market is segmented into tank electrotransfer, semi-dry electrotransfer, dry electrotransfer, and other transfer methods (diffusion blotting and vacuum blotting). The Dry electrotransfer segment is expected to grow at the fastest CAGR during the forecast period.

Regional Analysis

North America is expected to account for the largest share of the market in 2018, followed by Europe. The large share of North America can primarily be attributed to presence of leading transfer membrane manufacturers in the region, availability of government and private financial support for life science research, and a high disease prevalence in the region.

Key Market Players:

The key players in the transfer membrane market include Merck KGaA (US), Thermo Fisher Scientific (US), Bio-Rad Laboratories (US), GE Healthcare (US), PerkinElmer (US), Pall Coporation (US), Advansta (US), GVS (Italy), Santa Cruz Biotechnology (US), Abcam (UK), ATTO Corporation (Japan), Carl Roth (Germany), Macherey-Nagel (Germany), Azure Biosystems (US), and Axiva Sichem Biotech (India), among others.

[124 Pages Report] The transfer membrane market is projected to reach USD 187.9 million by 2023 from USD 174.8 million in 2018, at a CAGR of 1.5% during the forecast period.

Get Data as per your Format and Definition | REQUEST FOR CUSTOMIZATION @ https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=36975865

Merck KGaA (US) held the leadership position in the transfer membrane market. The company has a broad portfolio of transfer membrane. Apart from its broad product portfolio, the company also has a strong geographical presence and a wide customer base in emerging economies, including Brazil, India, and China.